Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jonathan Corren

Showing results (91-100 of 141) with videos related to

Pageof 15
Sort By:
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|May 11, 2019
Dupilumab improves asthma outcomes irrespective of frequency of previous asthma exacerbation historyJonathan Corren, Mario Castro, Linda B Ford, et al.
Chest|July 8, 2009
Criteria to screen for chronic sinonasal diseaseAnne E Dixon, Elizabeth A Sugar, S James Zinreich, et al.
The European Respiratory Journal|July 16, 2021
Effect of exacerbation history on clinical response to dupilumab in moderate-to-severe uncontrolled asthmaJonathan Corren, Constance H Katelaris, Mario Castro, et al.
Immunotherapy|September 29, 2023
Tezepelumab for the treatment of severe asthma: a plain language summary of the PATHWAY and NAVIGATOR studiesJonathan Corren, Andrew Menzies-Gow, Johan Bimmel, et al.
The Journal of Allergy and Clinical Immunology|June 12, 2020
Efficacy and safety of omalizumab in nasal polyposis: 2 randomized phase 3 trialsPhilippe Gevaert, Theodore A Omachi, Jonathan Corren, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|August 24, 2018
Dupilumab improves symptoms, quality of life, and productivity in uncontrolled persistent asthmaJonathan Corren, Mario Castro, Pascal Chanez, et al.
The New England Journal of Medicine|May 12, 2021
Tezepelumab in Adults and Adolescents with Severe, Uncontrolled AsthmaAndrew Menzies-Gow, Jonathan Corren, Arnaud Bourdin, et al.
The Journal of Allergy and Clinical Immunology|November 8, 2006
Small airways response to naturalistic cat allergen exposure in subjects with asthmaMichelle R Zeidler, Jonathan G Goldin, Eric C Kleerup, et al.
The Journal of Allergy and Clinical Immunology. in Practice|March 30, 2024
Dupilumab Reduces Exacerbations Independent of Changes in Biomarkers in Moderate-to-Severe AsthmaIan D Pavord, Thomas B Casale, Jonathan Corren, et al.
Journal of Asthma and Allergy|September 11, 2023
Tezepelumab Efficacy in Patients with Severe, Uncontrolled Asthma with Comorbid Nasal Polyps in NAVIGATORTanya M Laidlaw, Andrew Menzies-Gow, Scott Caveney, et al.
Pageof 15

Showing results (91-100 of 141) with videos related to

Sort By:
Pageof 15
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|May 11, 2019
Dupilumab improves asthma outcomes irrespective of frequency of previous asthma exacerbation historyJonathan Corren, Mario Castro, Linda B Ford, et al.
Chest|July 8, 2009
Criteria to screen for chronic sinonasal diseaseAnne E Dixon, Elizabeth A Sugar, S James Zinreich, et al.
The European Respiratory Journal|July 16, 2021
Effect of exacerbation history on clinical response to dupilumab in moderate-to-severe uncontrolled asthmaJonathan Corren, Constance H Katelaris, Mario Castro, et al.
Immunotherapy|September 29, 2023
Tezepelumab for the treatment of severe asthma: a plain language summary of the PATHWAY and NAVIGATOR studiesJonathan Corren, Andrew Menzies-Gow, Johan Bimmel, et al.
The Journal of Allergy and Clinical Immunology|June 12, 2020
Efficacy and safety of omalizumab in nasal polyposis: 2 randomized phase 3 trialsPhilippe Gevaert, Theodore A Omachi, Jonathan Corren, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|August 24, 2018
Dupilumab improves symptoms, quality of life, and productivity in uncontrolled persistent asthmaJonathan Corren, Mario Castro, Pascal Chanez, et al.
The New England Journal of Medicine|May 12, 2021
Tezepelumab in Adults and Adolescents with Severe, Uncontrolled AsthmaAndrew Menzies-Gow, Jonathan Corren, Arnaud Bourdin, et al.
The Journal of Allergy and Clinical Immunology|November 8, 2006
Small airways response to naturalistic cat allergen exposure in subjects with asthmaMichelle R Zeidler, Jonathan G Goldin, Eric C Kleerup, et al.
The Journal of Allergy and Clinical Immunology. in Practice|March 30, 2024
Dupilumab Reduces Exacerbations Independent of Changes in Biomarkers in Moderate-to-Severe AsthmaIan D Pavord, Thomas B Casale, Jonathan Corren, et al.
Journal of Asthma and Allergy|September 11, 2023
Tezepelumab Efficacy in Patients with Severe, Uncontrolled Asthma with Comorbid Nasal Polyps in NAVIGATORTanya M Laidlaw, Andrew Menzies-Gow, Scott Caveney, et al.
Pageof 15